These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25701027)

  • 41. Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors.
    Song RF; Li XJ; Cheng XL; Fu AR; Wang YH; Feng YJ; Xiong Y
    Oncol Rep; 2014 Oct; 32(4):1481-8. PubMed ID: 25051142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor environment differentiated "nanodepot" programmed for site-specific drug shuttling and combinative therapy on metastatic cancer.
    Dong Q; Zhang H; Han Y; Djamila A; Cheng H; Tang Z; Zhou J; Ding Y
    J Control Release; 2018 Aug; 283():59-75. PubMed ID: 29803613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
    Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
    Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
    Yu B; Tang C; Yin C
    Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts.
    Takei Y; Kadomatsu K; Goto T; Muramatsu T
    Cancer; 2006 Aug; 107(4):864-73. PubMed ID: 16832814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The inhibition of metastasis and growth of breast cancer by blocking the NF-κB signaling pathway using bioreducible PEI-based/p65 shRNA complex nanoparticles.
    Xiao J; Duan X; Yin Q; Miao Z; Yu H; Chen C; Zhang Z; Wang J; Li Y
    Biomaterials; 2013 Jul; 34(21):5381-90. PubMed ID: 23591394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
    Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
    Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted Dual pH-Sensitive Lipid ECO/siRNA Self-Assembly Nanoparticles Facilitate In Vivo Cytosolic sieIF4E Delivery and Overcome Paclitaxel Resistance in Breast Cancer Therapy.
    Gujrati M; Vaidya AM; Mack M; Snyder D; Malamas A; Lu ZR
    Adv Healthc Mater; 2016 Nov; 5(22):2882-2895. PubMed ID: 27723260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics.
    Lay CL; Liu HQ; Tan HR; Liu Y
    Nanotechnology; 2010 Feb; 21(6):065101. PubMed ID: 20057024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.
    Sun TM; Du JZ; Yao YD; Mao CQ; Dou S; Huang SY; Zhang PZ; Leong KW; Song EW; Wang J
    ACS Nano; 2011 Feb; 5(2):1483-94. PubMed ID: 21204585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly.
    Hu Q; Li W; Hu X; Hu Q; Shen J; Jin X; Zhou J; Tang G; Chu PK
    Biomaterials; 2012 Sep; 33(27):6580-91. PubMed ID: 22717365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancer.
    Xue HY; Wong HL
    Eur J Pharm Biopharm; 2012 May; 81(1):24-32. PubMed ID: 22369881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
    Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
    J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer.
    Demečková V; Solár P; Hrčková G; Mudroňová D; Bojková B; Kassayová M; Gancarčiková S
    Biomed Pharmacother; 2017 May; 89():245-256. PubMed ID: 28235687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antimetastatic and anticancer activity of S-1, a new oral dihydropyrimidine-dehydrogenase-inhibiting fluoropyrimidine, alone and in combination with paclitaxel in an orthotopically implanted human breast cancer model.
    Nukatsuka M; Fujioka A; Nakagawa F; Oshimo H; Kitazato K; Uchida J; Sugimoto Y; Nagayama S; Fukushima M
    Int J Oncol; 2004 Dec; 25(6):1531-6. PubMed ID: 15547687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.